Ilieva, N.; Pencheva, M.; Hadzhiev, H.; Tashkova, D.; Daskalova, E.; Georgiev, P.; Genova, S.
Impact of Neoadjuvant Therapy on PD-L1 Expression in Triple-Negative Breast Cancer and Correlation with Clinicopathological Factors. Diagnostics 2024, 14, 2672.
https://doi.org/10.3390/diagnostics14232672
AMA Style
Ilieva N, Pencheva M, Hadzhiev H, Tashkova D, Daskalova E, Georgiev P, Genova S.
Impact of Neoadjuvant Therapy on PD-L1 Expression in Triple-Negative Breast Cancer and Correlation with Clinicopathological Factors. Diagnostics. 2024; 14(23):2672.
https://doi.org/10.3390/diagnostics14232672
Chicago/Turabian Style
Ilieva, Nevena, Mina Pencheva, Hristo Hadzhiev, Desislava Tashkova, Elena Daskalova, Petar Georgiev, and Sylvia Genova.
2024. "Impact of Neoadjuvant Therapy on PD-L1 Expression in Triple-Negative Breast Cancer and Correlation with Clinicopathological Factors" Diagnostics 14, no. 23: 2672.
https://doi.org/10.3390/diagnostics14232672
APA Style
Ilieva, N., Pencheva, M., Hadzhiev, H., Tashkova, D., Daskalova, E., Georgiev, P., & Genova, S.
(2024). Impact of Neoadjuvant Therapy on PD-L1 Expression in Triple-Negative Breast Cancer and Correlation with Clinicopathological Factors. Diagnostics, 14(23), 2672.
https://doi.org/10.3390/diagnostics14232672
